Skip to content

NTRA

Natera, Inc.

NASDAQ · USHealthcareMedical - Diagnostics & Research
$262.63-3.23%

Price as of Jul 20, 2026

NTRA growth

Natera, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+36.6%
EBITDA
-51.6%
EBIT
-42.7%
EPS
-10.9%
Free cash flow
+8.0%
Operating cash flow
+37.8%

Forward estimates

Revenue
+15.1%
EBITDA
EPS
+37.5%

Three-year CAGR

Revenue
+41.1%
EBITDA
-48.9%
EBIT
-39.4%
Net income
-9.3%
EPS
+0.7%
Free cash flow
+57.6%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.